Condition
Presbylarynx
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed3
Not Yet Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03702322Not ApplicableActive Not RecruitingPrimary
Improving Voice Production for Adults With Age-related Dysphonia
NCT06078527Not ApplicableNot Yet RecruitingPrimary
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
NCT04764604Not ApplicableCompleted
Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment
NCT03749863Not ApplicableCompletedPrimary
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
NCT03557775Not ApplicableCompletedPrimary
Respiratory Muscle Strength Training in Presbyphonia
Showing all 5 trials